NCT06445686View on ClinicalTrials.gov

Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation.

RecruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 17, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Idiopathic Pulmonary Fibrosis
Trial Locations (1)

35000

RECRUITING

Chru Pontchaillou, Rennes

Sponsors

Lead Sponsor

Biosency
All Listed Sponsors
collaborator

Rennes University Hospital

OTHER

collaborator

Air de Bretagne

UNKNOWN

collaborator

Association Fibroses Pulmonaires France

UNKNOWN

lead

Biosency

INDUSTRY

NCT06445686 - Ongoing Monitoring of Vital Signs in Patients With Idiopathic Pulmonary Fibrosis Before and After Acute Exacerbation. | Biotech Hunter | Biotech Hunter